OTC Nexium 24HR Rides Blockbuster History Into Full Field Of Competitors

Pfizer launches Nexium 24HR, the OTC progeny of AstraZeneca PLC’s prescription drug marketed in the U.S. as “the purple pill,” into the nonprescription PPI market, where other well-known brands and private label versions of some products already compete for share.